Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cytogenetics of
hepatocellular carcinoma
and adenoma have revealed gains of chromosome 1q as a significant differentiating factor. However, no studies are available comparing these amplification events with gene expression. Therefore, gene expression profiling was performed on tumours cytogenetically well characterized by array-based comparative genomic hybridisation. For this approach analysis was carried out on 24
hepatocellular carcinoma
and 8 hepatocellular adenoma cytogenetically characterised by array-based comparative genomic hybridisation. Expression profiles of mRNA were determined using a genome-wide microarray containing 43,000 spots. Hierarchical clustering analysis branched all hepatocellular adenoma from
hepatocellular carcinoma
. Significance analysis of microarray demonstrated 722 dysregulated genes in
hepatocellular carcinoma
. Gene set enrichment analysis detected groups of upregulated genes located in chromosome bands 1q22-42 seen also as the most frequently gained regions by comparative genomic hybridisation. Comparison of significance analysis of microarray and gene set enrichment analysis narrowed down the number of dysregulated genes to 18, with 7 genes localised on 1q22 (
SCAMP3
, IQGAP3, PYGO2, GPATC4, ASH1L, APOA1BP, and CCT3). In hepatocellular adenoma 26 genes in bands 11p15, 11q12, and 12p13 were upregulated. However, the respective chromosome bands were not gained in hepatocellular adenoma. Expression analysis and comparative genomic hybridisation identified an upregulation of genes in amplified regions of 1q. These results may serve to further narrow down the number of candidate driver genes in hepatocarcinogenesis.
...
PMID:Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions. 1827 65
SCAMP3
, an isoform of the secretory carrier membrane proteins (SCAMPs) family, is a membrane-trafficking protein involved in endosome transport. Previous microarray data showed that
SCAMP3
mRNA is highly expressed in
hepatocellular carcinoma
(
HCC
). In this study, the expression and clinical significance of
SCAMP3
in 100 pairs of
HCC
and adjacent normal tissue were investigated. siRNA transfection was performed to silence
SCAMP3
expression in
HCC
cells. The MTS assay and flow cytometry were used to detect the proliferation, cell cycle progression of
HCC
cells. Compared with adjacent normal tissues,
SCAMP3
expression was dramatically increased in
HCC
tissues demonstrated by Western blotting (
P
< 0.05). In immunohistochemistry, compared with the adjacent normal tissues,
SCAMP3
was detected in 96% of the
HCC
samples with a significant increase in intensity and number of stained cells (
P
< 0.05). Also, high
SCAMP3
expression was found in 86% of the
HCC
samples (
P
< 0.05). The increased
SCAMP3
expression was significantly correlated with vascular invasion (
P
= 0.004) and tumor stage (
P
= 0.001). Univariate and multivariate survival analyses showed that the expression of
SCAMP3
was an independent prognostic factor of overall survival of
HCC
patients. Knockdown of
SCAMP3
expression led to suppression of cell proliferation and blockage of cell cycle of
HCC
cells. In conclusion, our present study suggested that
SCAMP3
may serve as a promising prognostic biomarker and molecular target of
HCC
and further investigation is warranted.
...
PMID:Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma. 2931 5